国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Candida albicans RNA polymerase II degradation factor 1 (DEF1) CSB-YP685504CZD
CSB-EP685504CZD
CSB-BP685504CZD
CSB-MP685504CZD
CSB-EP685504CZD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida albicans 13 kDa ribonucleoprotein-associated protein (SNU13) CSB-YP685505CZD
CSB-EP685505CZD
CSB-BP685505CZD
CSB-MP685505CZD
CSB-EP685505CZD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida albicans Phosphatidylinositol transfer protein SFH5 (SFH5) CSB-YP685506CZD
CSB-EP685506CZD
CSB-BP685506CZD
CSB-MP685506CZD
CSB-EP685506CZD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida albicans Pre-mRNA-splicing factor CEF1 (CEF1), partial CSB-YP685507CZD
CSB-EP685507CZD
CSB-BP685507CZD
CSB-MP685507CZD
CSB-EP685507CZD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida albicans F-box protein COS111 (COS111), partial CSB-YP685508CZD
CSB-EP685508CZD
CSB-BP685508CZD
CSB-MP685508CZD
CSB-EP685508CZD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Emericella nidulans Lipoyl synthase, mitochondrial (AN9486) CSB-YP685509EKF
CSB-EP685509EKF
CSB-BP685509EKF
CSB-MP685509EKF
CSB-EP685509EKF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Emericella nidulans Alpha-glucuronidase A (aguA), partial CSB-YP685510EKF
CSB-EP685510EKF
CSB-BP685510EKF
CSB-MP685510EKF
CSB-EP685510EKF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Emericella nidulans Exopolygalacturonase X-2 (pgaX-2) CSB-YP685511EKF
CSB-EP685511EKF
CSB-BP685511EKF
CSB-MP685511EKF
CSB-EP685511EKF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Emericella nidulans GDP-mannose transporter 1 (gmt1), partial CSB-YP685512EKF
CSB-EP685512EKF
CSB-BP685512EKF
CSB-MP685512EKF
CSB-EP685512EKF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Emericella nidulans Assembly factor cbp4 (cbp4), partial CSB-YP685513EKF
CSB-EP685513EKF
CSB-BP685513EKF
CSB-MP685513EKF
CSB-EP685513EKF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Emericella nidulans Probable altered inheritance of mitochondria protein 13, mitochondrial (AN8690) CSB-YP685514EKF
CSB-EP685514EKF
CSB-BP685514EKF
CSB-MP685514EKF
CSB-EP685514EKF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Emericella nidulans Endopolygalacturonase AN8327 (AN8327) CSB-YP685515EKF
CSB-EP685515EKF
CSB-BP685515EKF
CSB-MP685515EKF
CSB-EP685515EKF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Emericella nidulans Structure-specific endonuclease subunit slx1 (slx1) CSB-YP685516EKF
CSB-EP685516EKF
CSB-BP685516EKF
CSB-MP685516EKF
CSB-EP685516EKF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Emericella nidulans Lactobacillus shifted protein (lbsA) CSB-YP685517EKF
CSB-EP685517EKF
CSB-BP685517EKF
CSB-MP685517EKF
CSB-EP685517EKF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Emericella nidulans Probable glucan endo-1,3-beta-glucosidase eglC (eglC) CSB-YP685518EKF
CSB-EP685518EKF
CSB-BP685518EKF
CSB-MP685518EKF
CSB-EP685518EKF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Emericella nidulans Probable beta-glucosidase J (bglJ), partial CSB-YP685519EKF
CSB-EP685519EKF
CSB-BP685519EKF
CSB-MP685519EKF
CSB-EP685519EKF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Emericella nidulans High osmolarity signaling protein sho1 (sho1), partial CSB-YP685520EKF1
CSB-EP685520EKF1
CSB-BP685520EKF1
CSB-MP685520EKF1
CSB-EP685520EKF1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Emericella nidulans JmjC domain-containing histone demethylation protein 1 (jhd1), partial CSB-YP685521EKF
CSB-EP685521EKF
CSB-BP685521EKF
CSB-MP685521EKF
CSB-EP685521EKF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Emericella nidulans Ubiquitin-like modifier-activating enzyme atg7 (atg7), partial CSB-YP685522EKF
CSB-EP685522EKF
CSB-BP685522EKF
CSB-MP685522EKF
CSB-EP685522EKF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Emericella nidulans Pre-mRNA-splicing factor cwc26 (cwc26) CSB-YP685523EKF
CSB-EP685523EKF
CSB-BP685523EKF
CSB-MP685523EKF
CSB-EP685523EKF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>